The cellular and molecular mechanisms of diabetic complications.
about
Pathway-selective insulin resistance and metabolic disease: the importance of nutrient fluxDoes PGE₁ vasodilator prevent orthopaedic implant-related infection in diabetes? Preliminary results in a mouse modelGlucose transport in brain and retina: implications in the management and complications of diabetes.Therapeutic potential of endothelin receptor antagonists in diabetes.Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathyExendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3β activity.The anti-diabetic bis(maltolato)oxovanadium(IV) decreases lipid order while increasing insulin receptor localization in membrane microdomains.Diabetes, glucose metabolism, and glaucoma: the 2005-2008 National Health and Nutrition Examination Survey.Diabetic LDL inhibits cell-cycle progression via STAT5B and p21(waf).Haemodynamics in microvascular complications in type 1 diabetes.Molecular mechanisms of diabetic cardiovascular disease.Diabetic complications and dysregulated innate immunity.Endothelins in chronic diabetic complications.Microvascular basement membranes in diabetes mellitus.Update on the management of diabetic polyneuropathies.Diabetes mellitus as a risk factor for glaucomatous optic neuropathy.Enhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus.The Association Between Primary Open Angle Glaucoma and Clustered Components of Metabolic Syndrome.Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes.Diabetes and the endothelium.Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicatSustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.C-Peptide effects on renal physiology and diabetes.Metabolic and molecular action of Trigonella foenum-graecum (fenugreek) and trace metals in experimental diabetic tissues.Epigenetic changes in diabetes.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Decreased paraoxonase 2 enzymatic activity in monocyte/macrophages cells. A comparative in vivo and in vitro study for diabetes.Temporal assessment of ribose treatment on self-assembled articular cartilage constructsFuture strategies to prevent renal microvascular disease complications in diabetes.The beta-specific protein kinase C inhibitor ruboxistaurin (LY333531) suppresses glucose-induced adhesion of human monocytes to endothelial cells in vitro.Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells.Elevated glucose attenuates agonist- and flow-stimulated endothelial nitric oxide synthase activity in microvascular retinal endothelial cells.A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension.Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy.BENEFICIAL EFFECTS OF EXOGENOUS CROSSLINKING AGENTS ON SELF-ASSEMBLED TISSUE ENGINEERED CARTILAGE CONSTRUCT BIOMECHANICAL PROPERTIES.High-glucose-induced metallothionein expression in endothelial cells: an endothelin-mediated mechanism.High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.
P2860
Q26820876-3B7F4BAF-652F-4A72-AFD3-CFB80BC75322Q28537680-1D2DDF9E-31EF-4ACE-9B16-4B358D9EABAEQ33737742-0D39980E-23F1-4836-AAD4-6BE978A3FDA7Q34090982-34895790-B24D-45A8-8FCD-0A17A2C217D2Q34103169-01F01344-0E35-4F28-9BFE-03B1E52DF3ACQ34118381-33F305D7-1172-41C5-9CD0-BFE8772B36B7Q34255639-E86F1F59-DF1A-4D12-854E-F7EB6EEE5BB5Q34262663-B033A975-8BC7-461A-A0A8-D7F4B12E989DQ34506311-FB82F4DB-B60D-4D90-BC8B-8CFD81B19C4CQ34786460-3684F643-0028-4972-B01E-0763035EFED6Q34804249-1D874F17-ED8D-4634-8F53-7C37B98EFF0DQ34989681-1AEBF1F4-48A5-4D98-B9D2-7872E95F2A81Q35087841-2C3E2C74-F51F-4AF7-A71E-F9EF9C4ED2EEQ35168430-B944A32A-52D9-4EA8-9729-A522695CE12DQ35170462-A0BB2CB9-D975-4D00-BE0D-D19B3C161DC5Q35178801-D17EA9E9-8B2C-4D63-8351-64156359A35EQ35997726-294329EB-D0DC-493B-8D9D-484CF3D4EDE0Q36204680-07F001BD-E162-4C61-B1D4-8BCF342D0C64Q36232318-A2A3C620-B2AD-418C-AB20-E872557C832DQ36572832-1A554002-C4C7-4A78-A345-6C4934541EDFQ36839528-539E591B-9F0A-44C4-A047-22EC8D7D1521Q36966060-91E55D39-B531-4493-B168-B07073EF8D07Q37054987-5CF39105-7968-4E7F-A450-532CC1FFF789Q37054992-38B643D5-157D-401F-BB90-CC96F8D564BEQ37054999-863C33B5-ADEB-43B9-8651-217EF36B8FFBQ37176072-E86A78F4-EF70-4158-9FB5-1A824E17BA34Q37886501-1FA8147E-B57D-412D-93E0-606DD16C7A72Q38080554-442E1AB0-92AA-4B75-B188-801587C8E752Q38620860-4D3AFD19-BE9B-4DB7-B531-2515B3753714Q38699500-01CAB6BA-069A-41F4-9722-222FC9512F15Q38811008-16AF7E61-9089-48FD-9E2B-987F345F68AAQ40139541-CF711540-7C94-49C0-BAC1-149C65C882ADQ41903325-1DC96C28-9225-4D31-834D-3D95CB12EEA0Q42479400-C7BAC5AF-78D8-4CAE-8184-80F743D6AAC6Q42509735-8C7D903F-80FB-4238-9CB4-DEFC32732D46Q42546068-CCD807C0-9BF1-4EE6-A1C2-39B0944B9AADQ43131789-73CAE166-0475-44BA-91E9-D87BABFEC986Q43133564-65D423A3-1B00-4D40-A3B6-D096BB41C57AQ43705413-2F6F8128-AB27-4B49-957D-D41F3591F58EQ44185271-07FDF718-2E0F-4168-9805-517CD28A9DF0
P2860
The cellular and molecular mechanisms of diabetic complications.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The cellular and molecular mechanisms of diabetic complications.
@en
type
label
The cellular and molecular mechanisms of diabetic complications.
@en
prefLabel
The cellular and molecular mechanisms of diabetic complications.
@en
P1476
The cellular and molecular mechanisms of diabetic complications.
@en
P2093
P304
P356
10.1016/S0889-8529(05)70324-8
P577
1996-06-01T00:00:00Z